Substantial evidence indicates a pathogenic role of YKL-40 in endothelial dysfunction and the earliest part of the atherosclerotic process leading to disease progression and manifest cardiovascular disease [1,2,3]. This evidence concerns the gene CHI3L1 and cardiovascular disorder.